Jonathan Lim
Founder presso BOUNDLESS BIO, INC.
Patrimonio netto: 76 M $ in data 31/03/2024
Profilo
Jonathan E.
Lim is the founder of Eclipse Therapeutics, Inc. (2011), Bonti, Inc. (2015), Boundless Bio, Inc. (2018), City Hill Ventures LLC (2010), Ignyta, Inc. (2011), Erasca, Inc. (2018), and Ignyta Operating, Inc. (2011).
Dr. Lim is also the founder of Medenovo Management LLC.
Dr. Lim's current job(s) include being a Director at Maze Therapeutics, Inc. (since 2019), a Member-Interdisciplinary Biosciences Council at Stanford University (since 2014), a Venture Partner at ARCH Venture Partners LLC (since 2018), a Member-Overseers Board at The Scripps Research Institute (since 2018), and a Member-Visitors Board at Moores Cancer Center (since 2015).
Dr. Lim's former job(s) include being the President, Chief Executive Officer & Director at Halozyme Therapeutics, Inc. (2005-2010), an Independent Non-Executive Director at Bionomics Ltd.
(2013-2015), and a Member-Strategic Planning Committee at American Medical Association (2002-2005).
Dr. Lim's education history includes attending Stanford University for undergraduate and graduate degrees, Harvard University for a graduate degree, and McGill University for a doctorate degree.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ERASCA, INC.
21.42% | 05/02/2024 | 32 355 576 ( 21.42% ) | 67 M $ | 31/03/2024 |
BOUNDLESS BIO INC.
4.09% | 02/04/2024 | 653 479 ( 4.09% ) | 9 M $ | 31/03/2024 |
Posizioni attive di Jonathan Lim
| Società | Posizione | Inizio |
|---|---|---|
| ERASCA, INC. | Chief Executive Officer | 19/03/2019 |
| BOUNDLESS BIO, INC. | Founder | 10/04/2018 |
| Moores Cancer Center | Corporate Officer/Principal | 01/01/2015 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01/10/2018 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | 01/12/2018 |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Director/Board Member | 23/10/2019 |
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Chief Executive Officer | 01/08/2011 |
City Hill Ventures LLC
 City Hill Ventures LLC Investment ManagersFinance City Hill Ventures LLC (City Hill Ventures) is a venture capital firm founded in 2010 by Jonathan Lim. The firm is headquartered in San Diego, California. | Founder | 18/04/2011 |
| Stanford University | Corporate Officer/Principal | 01/01/2014 |
Precedenti posizioni note di Jonathan Lim
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Jonathan Lim
| Harvard University | Graduate Degree |
| Stanford University | Graduate Degree |
| McGill University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| BIONOMICS LIMITED | Health Technology |
| ERASCA, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Aziende private | 10 |
|---|---|
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Commercial Services |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Health Technology |
Eclipse Therapeutics, Inc.
 Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. They are also implicated in resistance to current standard of care cancer treatments. Eclipse is leveraging its deep expertise in cancer stem cell biology and therapeutic antibodies to develop novel therapeutics that address unmet needs in cancer patient care. Eliminating cancer stem cells, in conjunction with other therapies that address the tumor bulk, represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemo resistance. The company was founded in March 2011 by former Biogen Idec employees, Peter Chu, Christopher Reyes and Jonathan Lim and is headquartered in San Diego, CA. | Health Technology |
City Hill Ventures LLC
City Hill Ventures LLC Investment ManagersFinance City Hill Ventures LLC (City Hill Ventures) is a venture capital firm founded in 2010 by Jonathan Lim. The firm is headquartered in San Diego, California. | Finance |
Medenovo Management LLC
 Medenovo Management LLC Medical SpecialtiesHealth Technology Medenovo Management LLC provides medical devices. The company was founded by Jonathan E. Lim and Eugene G. Chen and is headquartered in San Diego, CA. | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Bonti, Inc.
 Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Commercial Services |
| Moores Cancer Center |
- Borsa valori
- Insiders
- Jonathan Lim
